Pulmonary exacerbation
Showing 76 - 100 of >10,000
COPD Moderate, COPD Severe, Acute Exacerbation of COPD Trial (Neuromuscular Electrical Nerve Stimulation, Usual Physiotherapy
Not yet recruiting
- Chronic Obstructive Pulmonary Disease Moderate
- +2 more
- Neuromuscular Electrical Nerve Stimulation
- Usual Physiotherapy treatment (Chest Physiotherapy and mobility)
- (no location specified)
Sep 13, 2022
COPD (COPD), Exacerbation Copd, Muscle Atrophy Trial in Montpellier (Comparison of clinical and biological characteristics of
Terminated
- Chronic Obstructive Pulmonary Disease (COPD)
- +2 more
- Comparison of clinical and biological characteristics of patients
-
Montpellier, FranceMontpellier University Hospital Arnaud de Villeneuve Hospital
Dec 20, 2021
COPD Exacerbation, COPD, Acute Copd Exacerbation Trial in Netherlands (Procalcitonin, Physician's decision)
Recruiting
- COPD Exacerbation
- +2 more
- Procalcitonin
- Physician's decision
-
Heerlen, Limburg, Netherlands
- +10 more
May 9, 2023
Acute Exacerbation of Bronchiectasis Trial in Shanghai (anti-infective therapy sitafloxacin, anti-infective therapy
Active, not recruiting
- Acute Exacerbation of Bronchiectasis
- anti-infective therapy sitafloxacin
- anti-infective therapy levofloxacin
-
Shanghai, Shanghai, ChinaShanghai pulmonary hospital
Apr 5, 2022
COPD Exacerbation, Pneumonia, Hypoxemia Trial (Masimo oximeter, Nellcor oximeter, Nonin oximeter)
Not yet recruiting
- COPD Exacerbation
- +3 more
- Masimo oximeter
- +2 more
- (no location specified)
Apr 14, 2023
COPD, COPD Exacerbation, COPD Bronchitis Trial in Antwerp, Copenhagen, Leicester (Tezepelumab, Placebo)
Not yet recruiting
- COPD
- +4 more
- Tezepelumab
- Placebo
-
Antwerp, Belgium
- +2 more
Aug 17, 2022
Pulmonary Disease, Chronic Obstructive Trial in Orléans (Noninvasive ventilation, High-Flow Nasal Oxygen therapy)
Recruiting
- Pulmonary Disease, Chronic Obstructive
- Noninvasive ventilation
- High-Flow Nasal Oxygen therapy
-
Orléans, FranceCHR d'Orléans
Oct 22, 2021
COPD Trial in Shenzhen (Intervention group, control group)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Intervention group
- control group
-
Shenzhen, Guang Dong, ChinaShenzhen People's Hospital
Dec 16, 2022
Chronic Obstr Lung Disease Trial in Cairo (interleukin 6)
Completed
- Chronic Obstr Lung Disease
- interleukin 6
-
Cairo, EgyptBeni Suef university
Jan 27, 2022
Copd, COPD Exacerbation, Smoking Trial in Bialystok (Atorvastatin 40 Mg Oral Tablet, Placebo)
Recruiting
- Copd
- +4 more
- Atorvastatin 40 Mg Oral Tablet
- Placebo
-
Bialystok, PolandMedical University Hospital
Jul 22, 2022
Acute Exacerbation, Idiopathic Pulmonary Fibrosis, Home Spirometry Trial in Germany (Home spirometry)
Completed
- Acute Exacerbation
- +2 more
- Home spirometry
-
Gießen, Germany
- +3 more
Oct 26, 2021
Pulmonary Disease, Chronic Obstructive Trial
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- (no location specified)
Aug 27, 2021
Frequent Severe Exacerbations of AECOPD
Completed
- Chronic Obstructive Lung Disease
- +2 more
- Frequency of AECOPD
-
Ankara, TurkeyAnkara University Faculty of Medicine
Aug 16, 2022
COPD Exacerbation Trial in Halle, Nahariya (SenseGuard)
Recruiting
- COPD Exacerbation
- SenseGuard
-
Halle, Germany
- +1 more
Mar 14, 2022
COPD Exacerbation Trial in Hamilton (Heated Humidified High-flow Nasal Cannula)
Active, not recruiting
- COPD Exacerbation
- Heated Humidified High-flow Nasal Cannula
-
Hamilton, Ontario, CanadaSt. Joseph's Healthcare Hamilton
Apr 6, 2022
Use of PARniv for Early Diagnosis of LVF in AECOPD
Completed
- Acute Heart Failure
- COPD Exacerbation
- non invasive ventilation
-
Monastir, TunisiaUniversity hospital of Monastir
May 26, 2022
Acute Exacerbation of COPD, Lung Diseases, Lung Diseases, Obstructive Trial in Hong Kong (The intervention (CRP-guided) group)
Not yet recruiting
- Acute Exacerbation of COPD
- +4 more
- The intervention (CRP-guided) group
-
Hong Kong, Hong KongQueen Mary Hospital
May 16, 2022
Pulmonary Disease, Chronic Obstructive, Airway Disease, COPD Exacerbation Trial in San Francisco (Ozone exposure)
Active, not recruiting
- Pulmonary Disease, Chronic Obstructive
- +4 more
- Ozone exposure
-
San Francisco, California
- +2 more
Jun 6, 2022
COPD Exacerbation Acute, COPD With Acute Lower Respiratory Infection, Rhinovirus Trial (Vapendavir, Placebo)
Not yet recruiting
- COPD Exacerbation Acute
- +35 more
- Vapendavir
- Placebo
- (no location specified)
Nov 20, 2023
COPD Exacerbation, COPD Trial in Uppsala (EP395 (Part A and B), Verapamil (Part A), Midazolam (Part B))
Recruiting
- Chronic Obstructive Pulmonary Disease Exacerbation
- COPD
- EP395 (Part A and B)
- +3 more
-
Uppsala, SwedenClinical Trial Consultants AB
Nov 1, 2023
Idiopathic Pulmonary Fibrosis With Acute Exacerbation Trial in Seoul (Routine steroid administration group, Steroid pulse
Recruiting
- Idiopathic Pulmonary Fibrosis With Acute Exacerbation
- Routine steroid administration group
- Steroid pulse therapy group
-
Seoul, Korea, Republic ofDivision of Pulmonology, Department of Internal Medicine, Severa
Aug 6, 2021
COPD Exacerbation Trial in Vienna (digital mindfulness-based intervention (MBI))
Recruiting
- Chronic Obstructive Pulmonary Disease Exacerbation
- digital mindfulness-based intervention (MBI)
-
Vienna, AustriaKlinik Ottakring
Aug 17, 2022
COPD, COPD Exacerbation Trial in Shanghai (aerosol inhaled Amikacin Sulfate Injection, conventional therapy)
Not yet recruiting
- COPD
- COPD Exacerbation
- aerosol inhaled Amikacin Sulfate Injection
- conventional therapy
-
Shanghai, Shanghai, China
- +4 more
Feb 7, 2022
Acute Exacerbation of COPD, Pulmonary Disease, Chronic Obstructive, COPD Trial (Mobile Medical and bundle management, Mobile
Not yet recruiting
- Acute Exacerbation of COPD
- +7 more
- Mobile Medical and bundle management
- Mobile Medical and standard of care
- (no location specified)
Jan 22, 2022